Effects of PTH (1–84) on bone quality in a validated model of osteoporosis due to androgenic deprivation

References

• Dawson-Hughes B, Looker AC, Tosteson ANA, et al. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns. Osteoporosis Int 2010;21:41–52
   PubMed Web of Science ®Google Scholar
• Kamel HK. Male osteoporosis: new trends in diagnosis and therapy. Drugs Aging 2005;22:741–8
   PubMed Web of Science ®Google Scholar
• Riggs BL, Khosla S, Melton LJ. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002;23:279–302
   PubMed Web of Science ®Google Scholar
• Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 2007;357:905–16
   PubMed Web of Science ®Google Scholar
• Kurland ES, Cosman F, McMahon DJ, et al. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. J Clin Endocrinol Metab 2000;85:3069–76
   PubMed Web of Science ®Google Scholar
• Miyakoshi N. Effects of parathyroid hormone on cancellous bone mass and structure in osteoporosis. Curr Pharm Des 2004;10:2615–27
   PubMedGoogle Scholar
• Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434–41
   PubMed Web of Science ®Google Scholar
• Greenspan SL, Bone HG, Ettinger MP, et al. Effect of recombinant human parathyroid hormone (1–84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med 2007;146:326–39
   PubMed Web of Science ®Google Scholar
• Hock JM. Anabolic actions of PTH in the skeletons of animals. J Musculoskelet Neuronal Interact 2001;2:33–47
   PubMedGoogle Scholar
• Poole KES, Reeve J. Parathyroid hormone – a bone anabolic and catabolic agent. Curr Opin Pharmacol 2005;5:612–17
   PubMedGoogle Scholar
• Hock JM, Gera I, Fonseca J, Raisz LG. Human parathyroid hormone-(1–34) increases bone mass in ovariectomized and orchidectomized rats. Endocrinology 1988;122:2899–904
   PubMed Web of Science ®Google Scholar
• Hori M, Uzawa T, Morita K, et al. Effect of human parathyroid hormone (PTH(1–34)) on experimental osteopenia of rats induced by ovariectomy. Bone Miner 1988;3:193–9
   PubMedGoogle Scholar
• Stanislaus D, Devanarayan V, Hock JM. In vivo comparison of activated protein-1 gene activation in response to human parathyroid hormone (hPTH)(1–34) and hPTH(1–84) in the distal femur metaphyses of young mice. Bone 2000;27:819–26
   PubMedGoogle Scholar
• Kimmel DB, Bozzato RP, Kronis KA, et al. The effect of recombinant human (1–84) or synthetic human (1–34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats. Endocrinology 1993;132:1577–84
   PubMed Web of Science ®Google Scholar
• Ejersted C, Andreassen TT, Oxlund H, et al. Human parathyroid hormone (1–34) and (1–84) increase the mechanical strength and thickness of cortical bone in rats. J Bone Miner Res 1993;8:1097–101
   PubMedGoogle Scholar
• Borchers RE, Gibson LJ, Burchardt H, Hayes WC. Effects of selected thermal variables on the mechanical properties of trabecular bone. Biomaterials 1995;16:545–51
   PubMed Web of Science ®Google Scholar
• Gala Paniagua J, Díaz-Curiel M, De la Piedra Gordo C, et al. Bone mass assessment in rats by dual energy X-ray absorptiometry. Br J Radiol 1998;71:754–8
   PubMed Web of Science ®Google Scholar
• Feldkamp L, Davis L, Kress J. Practical cone-beam algorithms. J Opt Soc Am A 1984;6:612–19
   Google Scholar
• Hildebrand T, Ruegsegger P. A new method for the model-independent assessment of thickness in three-dimensional images. J Microsc 1997;185:67–75
   Web of Science ®Google Scholar
• Ulrich D, Van Rietbergen B, Laib A, Rüegsegger P. The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone 1999;25:55–60
   PubMed Web of Science ®Google Scholar
• Hildebrand T, Rüegsegger P. Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Engin 1997;1:15–23
   PubMedGoogle Scholar
• Harrigan TP, Mann RW. Characterization of microstructural anisotropy in orthotropic materials using a second rank tensor. J Mater Sci 1984;19:761–7
   Web of Science ®Google Scholar
• Hahn M, Vogel M, Pompesius-Kempa M, Delling G. Trabecular bone pattern factor – a new parameter for simple quantification of bone microarchitecture. Bone 1992;13:327–30
   PubMed Web of Science ®Google Scholar
• Turner CH, Burr DB. Basic biomechanical measurements of bone: a tutorial. Bone 1993;14:595–608
   PubMed Web of Science ®Google Scholar
• Wink CS, Felts WJ. Effects of castration on the bone structure of male rats: a model of osteoporosis. Calcif Tissue Int 1980;32:77–82
   PubMed Web of Science ®Google Scholar
• Vanderschueren D, Van Herck E, Schot P, et al. The aged male rat as a model for human osteoporosis: evaluation by nondestructive measurements and biomechanical testing. Calcif Tissue Int 1993;53:342–7
   PubMed Web of Science ®Google Scholar
• Montero M, Serfati D, Luna S, et al. The effectiveness of intermittent rat parathyroid hormone (1–34) treatment on low bone mass due to oestrogen or androgen depletion in skeletally mature rats. Aging Male 2010;13:59–73
   PubMed Web of Science ®Google Scholar
• Tezval M, Serferaz G, Rack T, et al. Effect of parathyroid hormone on hypogonadism induced bone loss of proximal femur of orchiectomized rat. World J Urol 2011;29:529–34
   PubMedGoogle Scholar
• Fox J, Miller MA, Newman MK, et al. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1–84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength. Calcif Tissue Int 2006;79:262–72
   PubMed Web of Science ®Google Scholar
• Curiel MD, Calero JA, Guerrero R, et al. Effects of LY-117018 HCl on bone remodeling and mineral density in the oophorectomized rat. Am J Obstet Gynecol 1998;178:320–5
   PubMedGoogle Scholar
• Kimmel DB. Animal models in osteoporosis research. In: Bilezekian J, Raisz L, Rodan G, eds. Principles of bone biology. San Diego, CA: Academic; 2002:1635–55
   Google Scholar
• Jolette J, Wilker CE, Smith SY, et al. Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1–84 in a 2-year study in Fischer 344 rats. Toxicol Pathol 2006;34:929–40
   PubMed Web of Science ®Google Scholar
• Vahle JL, Long GG, Sandusky G, et al. Bone neoplasms in F344 rats given teriparatide [rhPTH(1–34)] are dependent on duration of treatment and dose. Toxicol Pathol 2004;32:426–38
   PubMed Web of Science ®Google Scholar
• Francisco JI, Yu Y, Oliver RA, Walsh WR. Relationship between age, skeletal site, and time post-ovariectomy on bone mineral and trabecular microarchitecture in rats. J Orthop Res 2011;29:189–96
   PubMedGoogle Scholar
• Hernandes L, Ramos AL, Micheletti KR, et al. Densitometry, radiography, and histological assessment of collagen as methods to evaluate femoral bones in an experimental model of osteoporosis. Osteoporosis Int 2012;23:467–73
   PubMedGoogle Scholar
• Audran M, Chappard D, Legrand E, et al. Bone microarchitecture and bone fragility in men: DXA and histomorphometry in humans and in the orchidectomized rat model. Calcif Tissue Int 2001;69:214–17
   PubMed Web of Science ®Google Scholar
• Bagi CM, Hanson N, Andresen C, et al. The use of micro-CT to evaluate cortical bone geometry and strength in nude rats: correlation with mechanical testing, pQCT and DXA. Bone 2006;38:136–44
   PubMedGoogle Scholar
• De La Piedra C, Quiroga I, Montero M, et al. Daily or monthly ibandronate prevents or restores deteriorations of bone mass, architecture, biomechanical properties and markers of bone turnover in androgen-deficient aged rats. Aging Male 2011;14:220–30
   PubMed Web of Science ®Google Scholar
• Rissanen JP, Suominen MI, Peng Z, Halleen JM. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model. Calcif Tissue Int 2008;82:108–15
   PubMed Web of Science ®Google Scholar
• Vanderschueren D, Van Herck E, Suiker AM, et al. Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. Endocrinology 1992;130:2906–16
   PubMed Web of Science ®Google Scholar
• Hodsman AB, Fraher LJ, Ostbye T, et al. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis. J Clin Invest 1993;91:1138–48
   PubMed Web of Science ®Google Scholar